Last update 16 May 2026

FT-4101

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
FT 4101
Target
FASN
Action
inhibitors
Mechanism
FAS inhibitors(Fatty acid synthase inhibitors)
Therapeutic Areas
Digestive System DisordersEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Metabolic Dysfunction Associated SteatohepatitisObesity
Originator Organization
Forma Therapeutics Holdings, Inc.
Active Organization-
Inactive Organization
Forma Therapeutics, Inc.Forma Therapeutics, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FT-4101
NCT04004325
/ TerminatedPhase 1/2
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability and Efficacy of FT-4101 in Overweight/Obese Subjects With NASH
100 Clinical Results associated with FT-4101
Login to view more data
100 Translational Medicine associated with FT-4101
Login to view more data
100 Patents (Medical) associated with FT-4101
Login to view more data
100 Deals associated with FT-4101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic Dysfunction Associated SteatohepatitisPhase 2
United States
Forma Therapeutics, Inc.Forma Therapeutics, Inc.
17 May 2019
ObesityPhase 2
United States
Forma Therapeutics, Inc.Forma Therapeutics, Inc.
17 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04004325 (CTgov)
Phase 1/2
Metabolic Dysfunction Associated Steatohepatitis | Obesity
14
(FT-4101 3.0 mg)
mmkwqzcsls = yfzvtrdiwm xakgjasdoh (dpluftnkkp, wrjgdbaexj - mdflmtbawl)
View more
-
21 Nov 2024
placebo+FT-4101
(Placebo)
mmkwqzcsls = zkeovwslqy xakgjasdoh (dpluftnkkp, xqhglnwhpz - wqutwiqqmo)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free